BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12148447)

  • 1. Hepatitis C in children and adolescents: mode of acquisition, natural history and treatment.
    Stephenne X; Sokal EM
    Acta Gastroenterol Belg; 2002; 65(2):95-8. PubMed ID: 12148447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatitis C virus infection in childhood.
    Galoppo M; Galoppo C
    Ann Hepatol; 2010; 9 Suppl():98-102. PubMed ID: 20714004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C in children.
    Sehgal S; Jackson Allen PL
    Pediatr Nurs; 2004; 30(5):409-13. PubMed ID: 15587536
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
    Baker RD; Dee D; Baker SS
    J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
    Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
    Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
    AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of interferon in combination with ribavirin on the plus and minus strands of hepatitis C virus RNA in patients with hepatitis].
    He Y; Liu W; Zeng L
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):32-5. PubMed ID: 9275644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
    Neff GW; O'Brien CB; Cirocco R; Montalbano M; de Medina M; Ruiz P; Khaled AS; Bejarano PA; Safdar K; Hill MA; Tzakis AG; Schiff ER
    Liver Transpl; 2004 May; 10(5):595-8. PubMed ID: 15108250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child?
    Serranti D; Buonsenso D; Ceccarelli M; Gargiullo L; Ranno O; Valentini P
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1057-67. PubMed ID: 22013729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.
    González-Peralta RP; Kelly DA; Haber B; Molleston J; Murray KF; Jonas MM; Shelton M; Mieli-Vergani G; Lurie Y; Martin S; Lang T; Baczkowski A; Geffner M; Gupta S; Laughlin M;
    Hepatology; 2005 Nov; 42(5):1010-8. PubMed ID: 16250032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving strategies to attack hepatitis C.
    Norton M
    GMHC Treat Issues; 1998 Dec; 12(12):1-5. PubMed ID: 11366019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
    Bizollon T; Ducerf C; Trépo C
    J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV.
    Dieterich DT; Purow JM; Rajapaksa R
    Semin Liver Dis; 1999; 19 Suppl 1():87-94. PubMed ID: 10349696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects of hepatitis C in women of child-bearing age].
    Lombay B; Gasztonyi B; Szalay F
    Orv Hetil; 2008 Jun; 149(22):1017-21. PubMed ID: 18508735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with hepatitis C.
    Rao GS; Molleston JP
    Curr Gastroenterol Rep; 2005 Feb; 7(1):37-44. PubMed ID: 15701297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of acute hepatitis C].
    Grangé JD
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B32-7. PubMed ID: 12180306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.